April 2026: There are now 73 pending lawsuits in MDL -3163 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation , which involves NAION claims against Rybelsus and other GLP-1 drugs
Action : Tirzepatide with B12 injections is administered by trained professionals in a safe and comfortable setting
Elevated estrogen in the follicular phase typically accelerates emptying, while progesterone in the luteal phase may slow it
However, our analysis revealed the opposite: patients with diabetes who were exposed to GLP-1 RAs had a substantially higher risk of being diagnosed with nAMD, with a shorter time to diagnosis, compared with propensity-matched patients who were unexposed. The researchers also revealed that this finding comes amid numerous reports in other literature of unexpected worsening of diabetic retinopathy following a rapid reduction in blood glucose levels
Company, purity of 95% (HPLC), Mumbai, India
(PubMed) Kastelein JJ, Maki KC, Susekov A, et al
